New treatment strategy targets somatostatin to prevent blood sugar drops in type 1 diabetes

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes.

Curaleaf Sells Stock at C$6

Curaleaf Announces C$16 Million Underwritten Offering of Subordinate Voting Shares NEW YORK, Sept. 28, 2023 /CNW/ – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”

Read More »